Response to "can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?": evaluation of CYP3A activity with microdoses of midazolam.
N Hohmann, B Halama, N Siller, G Mikus, W E Haefeli
Index: Clin. Pharmacol. Ther. 95(5) , 490-1, (2014)
Full Text: HTML
Abstract
Related Compounds
Related Articles:
2015-01-01
[Arch. Toxicol. 89(1) , 107-19, (2015)]
2014-10-15
[Biochem. Pharmacol. 91(4) , 543-51, (2014)]
2014-07-01
[G3 (Bethesda) 4(7) , 1247-58, (2014)]
2010-01-01
[Chem. Res. Toxicol. 23 , 171-83, (2010)]
2011-12-01
[J. Sci. Ind. Res. 65(10) , 808, (2006)]